A Cautionary Tale: The Rise of GLP-1s
This brief underscores the history of GLP-1 medications and makes …
02/26/2024
Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.
This brief underscores the history of GLP-1 medications and makes …
02/26/2024
By offering lower costs, more benefits and better outcomes, …
02/26/2024
ACHP issued a statement in response to CMS' CY 2025 …
02/01/2024
ACHP submitted a response to an RFI from the National …
01/31/2024
ACHP submitted a response to an RFI from Senator Bill …
01/22/2024
Morgan Health CEO Dan Mendelson joins the Healthy Dialogue podcast …
09/13/2022
ACHP applauds the Senate for passing the Inflation Reduction Act, …
08/07/2022
The Alliance of Community Health Plans has sent Congressional Leaders …
04/25/2022
ACHP responds to the Biden Administration's announcement of Medicare coverage …
04/07/2022
In his first State of the Union, President Biden recommitted …
03/02/2022
ACHP's Michael Bagel presents MA for Tomorrow as an opportunity for stakeholders to discuss the future of the MA program in the wake of MedPAC's report.
03/18/2024
Ceci Connolly, president and CEO of ACHP, released an updated statement in response to the Change Healthcare cyberattack.
03/18/2024
ACHP sent a letter to HHS about the nonprofit, community health plan response to the Change Healthcare cyberattack.
03/15/2024
Ceci Connolly, president and CEO of ACHP, released a statement about the ongoing Change Healthcare situation following the February 2024 cyberattack.
03/15/2024
ACHP issued a statement in response to Change Healthcare's cyberattack.
03/11/2024
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.